- Jan 2026
New findings show COVID-19 vaccine reactions in people with MS are generally mild and short-lived.
Latest
- Dec 2025
A look at what we're building for 2026.
New findings show COVID-19 vaccine reactions in people with MS are generally mild and short-lived.
- Dec 2024
Discover research on how COVID-19 affects people with MS, including insights on medications, vaccines, and the risks of Long COVID.
- Dec 2024
As we wrap up the year, don’t miss the opportunity to explore the intriguing research topics we covered in 2024 – just a click away!
- Nov 2024
We know how important research is to you. This month we feature how ACP is pioneering change in MS research, groundbreaking discoveries from ECTRIMS 2024, and more!
- Nov 2024
The iConquerMS RIDE Council recently received the Jury Special Award – the first global recognition for achievement in patient engagement!
- Nov 2024
The entire November newsletter in a quick, easy to read format!
- Nov 2024
Join studies looking at three new experimental therapies for MS, or research into the pregnancy experiences of people with physical disabilities.